Evidence map›Paper›PMID 37435359›Full record

ArticleMedical devices (Auckland, N.Z.)2023

3D Printing in the Fight Against Covid-19.

Paweł Płatek, Natalia Daniel, Kamil Cieplak, Marcin Sarzyński, Przemysław Siemiński, Bartosz Sadownik, Paweł Andruszkiewicz, Łukasz Wróblewski

Abstract read
In one paragraph

Article in Medical devices (Auckland, N.Z.), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Trial
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Paweł PłatekFaculty of Mechatronics, Armament and Aviation, Military University of Technology, Warsaw, Poland.ORCID 0000-0001-7626-6823
Natalia DanielFaculty of Mechatronics, Armament and Aviation, Military University of Technology, Warsaw, Poland.
Kamil CieplakFaculty of Mechatronics, Armament and Aviation, Military University of Technology, Warsaw, Poland.
Marcin SarzyńskiFaculty of Mechatronics, Armament and Aviation, Military University of Technology, Warsaw, Poland.
Przemysław SiemińskiFaculty of Automotive and Construction Machinery Engineering, Warsaw University of Technology, Warsaw, Poland.ORCID 0000-0002-5495-2336
Bartosz Sadownik2nd Department of Anaesthesiology and Intensive Care, Medical University of Warsaw, Central Teaching Hospital, Central Teaching Hospital, Warsaw, Poland.
Paweł Andruszkiewicz2nd Department of Anaesthesiology and Intensive Care, Medical University of Warsaw, Central Teaching Hospital, Central Teaching Hospital, Warsaw, Poland.
Łukasz Wróblewski2nd Department of Anaesthesiology and Intensive Care, Medical University of Warsaw, Central Teaching Hospital, Central Teaching Hospital, Warsaw, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: The paper describes the design concept and findings from technological and initial clinical trials conducted to develop a helmet for non-invasive oxygen therapy using positive pressure, known as hCPAP (Helmet Continuous Positive Airway Pressure). Methods: The study utilized PET-G filament, a recommended material for medical applications, along with the FFF 3D printing technique. Additional technological investigations were performed for the production of fitting components. The authors proposed a parameter identification method for 3D printing, which reduced the time and cost of the study while ensuring high mechanical strength and quality of the manufactured elements. Results: The proposed 3D printing technique facilitated the rapid development of an ad hoc hCPAP device, which was utilized in preclinical testing and treatment of Covid-19 patients, and yielded positive results. Based on the promising outcomes of the preliminary tests, further development of the hCPAP device's current version was pursued. Conclusion: The proposed approach offered a crucial benefit by significantly reducing the time and costs involved in developing customized solutions to aid in the fight against the Covid-19 pandemic.

Indexed as

3D printingCovid-19fused filament fabricationhCPAPrespiratory failureSARS-CoV-2

Identifiers

PMID37435359
PMCPMC10332420

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.